Publications | PubMed=6888561; DOI=10.1038/305245a0 Schwab M., Alitalo K., Klempnauer K.-H., Varmus H.E., Bishop J.M., Gilbert F., Brodeur G.M., Goldstein M.N., Trent J.M. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245-248(1983) DOI=10.1016/B978-0-12-333530-2.50006-X Israel M.A., Thiele C.J. Tumor cell lines of the peripheral nervous system. (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York (1994) DOI=10.1007/0-306-46872-7_2 Thiele C.J. Neuroblastoma. (In) Human cell culture. Vol. 1. Cancer Cell Lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York (1999) PubMed=11550280; DOI=10.1002/gcc.1174 Van Roy N., Van Limbergen H., Vandesompele J., Van Gele M., Poppe B., Salwen H.R., Laureys G., Manoel N., De Paepe A., Speleman F. Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines. Genes Chromosomes Cancer 32:126-135(2001) PubMed=15892104; DOI=10.1002/gcc.20198 Mosse Y.P., Greshock J., Margolin A.A., Naylor T., Cole K., Khazi D., Hii G., Winter C., Shahzad S., Asziz M.U., Biegel J.A., Weber B.L., Maris J.M. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43:390-403(2005) PubMed=16822308; DOI=10.1186/1471-2407-6-177 Dam V., Morgan B.T., Mazanek P., Hogarty M.D. Mutations in PIK3CA are infrequent in neuroblastoma. BMC Cancer 6:177.1-177.10(2006) PubMed=18724359; DOI=10.1038/nature07261 Mosse Y.P., Laudenslager M., Longo L., Cole K.A., Wood A., Attiyeh E.F., Laquaglia M.J., Sennett R., Lynch J.E., Perri P., Laureys G., Speleman F., Kim C., Hou C.-P., Hakonarson H., Torkamani A., Schork N.J., Brodeur G.M., Tonini G.P., Rappaport E., Devoto M., Maris J.M. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930-935(2008) PubMed=23202128; DOI=10.1038/ng.2493 Sausen M., Leary R.J., Jones S., Wu J., Reynolds C.P., Liu X.-Y., Blackford A.L., Parmigiani G., Diaz L.A. Jr., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E., Hogarty M.D. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 45:12-17(2013) PubMed=24466371; DOI=10.1593/tlo.13544 Loschmann N., Michaelis M., Rothweiler F., Zehner R., Cinatl J., Voges Y., Sharifi M., Riecken K., Meyer J., von Deimling A., Fichtner I., Ghafourian T., Westermann F., Cinatl J. Jr. Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs. Transl. Oncol. 6:685-696(2013) PubMed=25730103; DOI=10.1021/pr5011718 Hu Y.-L., Mayampurath A., Khan S., Cohen J.K., Mechref Y., Volchenboum S.L. N-linked glycan profiling in neuroblastoma cell lines. J. Proteome Res. 14:2074-2081(2015) PubMed=28350380; DOI=10.1038/sdata.2017.33 Harenza J.L., Diamond M.A., Adams R.N., Song M.M., Davidson H.L., Hart L.S., Dent M.H., Fortina P., Reynolds C.P., Maris J.M. Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci. Data 4:170033-170033(2017) |